Status:
COMPLETED
The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
Lead Sponsor:
Hartford Hospital
Conditions:
Coronary Artery Disease
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if magnesium can improve blood pressure, cholesterol, and blood sugar control in patients with implantable cardioverter defibrillators (ICDs).
Detailed Description
Magnesium is the second most abundant intracellular cation and plays a vital role in many physiologic processes. It has been determined that patients with cardiovascular disease have intracellular mag...
Eligibility Criteria
Inclusion
- Newly implanted ICD or recent ICD shock (within 6 months)
Exclusion
- Inability to swallow
- A non-cardiac disease with a survival prognosis of less than 12 months
- Hypermagnesemia
- Creatinine clearance less than 30mL/min
- Lactic acidosis or systemic acidosis syndrome
- Previous intolerance to magnesium L-lactate
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00282659
Start Date
January 1 2006
End Date
June 1 2008
Last Update
May 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06102-5037